AZN
AstraZeneca PLC
NYSE · Healthcare · Drug Manufacturers - General · GB
$163.95
−0.88%Forward multiples
Based on analyst estimates
- P/E forward
- 15.00x
- P/E 2026E
- 16.12x
- P/E 2027E
- 14.47x
- P/E 2028E
- 13.02x
- P/S forward
- 3.85x
Trailing multiples
Trailing twelve months
- P/E TTM
- 24.40x
- PEG TTM
- 0.39x
- Price / book
- 5.06x
- Price / sales
- 4.14x
- Price / cash flow
- 18.41x
Enterprise value
- Enterprise value
- $281.6B
- EV / sales
- 4.59x
- EV / EBITDA
- 13.61x
- EV / EBIT
- 20.15x
- Market cap
- $254.3B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026